Patients with ASCVD, especially those with a recent AMI, have a substantial risk of subsequent MACE at 1 year, highlighting the need for aggressive secondary prevention strategies.
This study found that the prevalence of ASCVD and the rate of subsequent MACE outcomes 1 year following the initial ASCVD event are substantial, particularly among patients with an AMI. Secondary prevention strategies aimed at lowering this risk are needed for patients with ASCVD.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: